Each three drop serving contains: Biologically Active Peptide Fragments of Collagen Type II (n1) 60 mcg. Other Ingredients: Distilled Water, Acetic Acid.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
Below is general information about the effectiveness of the known ingredients contained in the product Vital 3 Joint Solution. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Vital 3 Joint Solution. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the interactions of the known ingredients contained in the product Vital 3 Joint Solution. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the adverse effects of the known ingredients contained in the product Vital 3 Joint Solution. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...Orally, collagen type II seems to be well tolerated.
Most Common Adverse Effects:
Orally: Abdominal pain, constipation, nausea, and vomiting.
Cardiovascular ...Orally, one incident of mild hypertension was reported as being possibly related to collagen type II in a clinical trial of children (101719).
Dermatologic ...Orally, collagen type II might cause itching. In two cases, the itching was associated with skin eruption (44451,101717,101719).
Gastrointestinal ...Orally, the most common adverse effects of collagen type II reported in clinical studies are gastrointestinal and include constipation, nausea, vomiting, and abdominal pain. These occurred in up to 7% of patients taking collagen type II (44451,97238,97239,101717,101719). Anorexia was also reported, but this was much less common (44451).
Hematologic ...Orally, one incident each of blood in urine and a decrease in white blood cell count were reported for patients taking collagen type II in clinical research (101717).
Hepatic ...Orally, liver function abnormalities, including elevated transaminase levels, have been reported in some clinical research, but this is uncommon (3111,44451,101717).
Neurologic/CNS ...Orally, headache, dizziness, and insomnia have been reported for patients taking collagen type II in clinical studies, but these events are uncommon (44451,97238,97239,101717).
Renal ...Orally, one case of mild proteinuria was reported as being possibly related to use of collagen type II in a clinical trial of children (101719).
Other ...Orally, edema occurred in two patients taking collagen type II in clinical research (101717).
